Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Central Garden & Pet (CENT)

Central Garden & Pet FY2025 profit rises as sales slip; FY2026 EPS outlook $2.70+

Mixed Impact 3 of 5 earnings Written later

Central Garden & Pet reported fiscal 2025 net sales of $3.1 billion, down from $3.2 billion, while GAAP diluted EPS rose to $2.55 from $1.62 and non-GAAP diluted EPS rose to $2.73 from $2.13. The company expects fiscal 2026 non-GAAP EPS of $2.70 or better, which is slightly below the fiscal 2025 non-GAAP result, and the results are preliminary until its Form 10-K is filed.

Key points

  • Fiscal 2025 net sales were $3.1 billion versus $3.2 billion, a decrease of 2%.
  • Fiscal 2025 GAAP diluted EPS was $2.55 versus $1.62; non-GAAP diluted EPS was $2.73 versus $2.13.
  • Fourth-quarter net sales were $678 million versus $669 million, and the net loss narrowed to $10 million from $34 million.
  • Fiscal 2026 outlook calls for non-GAAP EPS of $2.70 or better and capital spending of $50 million to $60 million.

The filing

CompanyCentral Garden & Pet (CENT)
Form8-K, current report
Filed with the SECNov 24, 2025, 4:24 PM ET
Accession number0000887733-25-000035

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 24, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.